New generic drug for tuberculosis in india?

See below: India’s drug patent laws is being challenged in the country’s supreme court by the drug company novartis. If the challenge is successful it will restrict access of developing countries to generic drugs like those for tb. The law is strict against "evergreening" --keeps drugs out of the reach of generic manufacturers, and therefore, out of those who can't afford the "brand" name product.